Nandkumar M. Kamat In December 2019, a cluster of unusual pneumonia cases surfaced in Wuhan, China. Within weeks, the world ...

With the CHMP affirmation, Moderna is on course to get EU approval for its fourth vaccine product and break new ground in ...

Thermal scanning at ports of entry is not as effective in keeping rare deadly pathogens out as one may hope, says Hsu Li Yang from the Saw Swee Hock School of Public Health.

The University of Chicago will award honorary degrees to three distinguished scholars on June 6 during its Convocation ...

Emergency Care Reduction: The study of the 2024–2025 vaccine showed a 29.3% effectiveness (95% confidence interval [CI], 19.1 to 39.2) against Covid-19–related ED visits, preventing approximately 18.3 ...

Objective India had an estimated three to five million excess deaths from causes attributable to SARS-CoV-2 during 2020–2021, ...

COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...

A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, ...

Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, influenza, and Streptococcus pneumoniae (a cause of bacterial pneumonia) with a ...

COVID-19 vaccination during the 2024-2025 respiratory virus season was associated with protection against hospitalization.

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

Engineered M13 phage-based biosensor offers rapid, label-free detection of SARS-CoV-2 spike protein, demonstrating ...